1. Home
  2. MFI vs ENSC Comparison

MFI vs ENSC Comparison

Compare MFI & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MFI
  • ENSC
  • Stock Information
  • Founded
  • MFI 2002
  • ENSC 2003
  • Country
  • MFI Hong Kong
  • ENSC United States
  • Employees
  • MFI N/A
  • ENSC N/A
  • Industry
  • MFI
  • ENSC Biotechnology: Pharmaceutical Preparations
  • Sector
  • MFI
  • ENSC Health Care
  • Exchange
  • MFI NYSE
  • ENSC Nasdaq
  • Market Cap
  • MFI 9.9M
  • ENSC 7.9M
  • IPO Year
  • MFI 2024
  • ENSC N/A
  • Fundamental
  • Price
  • MFI $0.66
  • ENSC $6.00
  • Analyst Decision
  • MFI
  • ENSC
  • Analyst Count
  • MFI 0
  • ENSC 0
  • Target Price
  • MFI N/A
  • ENSC N/A
  • AVG Volume (30 Days)
  • MFI 283.9K
  • ENSC 52.1K
  • Earning Date
  • MFI 02-24-2025
  • ENSC 03-14-2025
  • Dividend Yield
  • MFI N/A
  • ENSC N/A
  • EPS Growth
  • MFI N/A
  • ENSC N/A
  • EPS
  • MFI N/A
  • ENSC N/A
  • Revenue
  • MFI $3,877,747.00
  • ENSC $4,421,404.00
  • Revenue This Year
  • MFI N/A
  • ENSC $89.78
  • Revenue Next Year
  • MFI N/A
  • ENSC N/A
  • P/E Ratio
  • MFI N/A
  • ENSC N/A
  • Revenue Growth
  • MFI N/A
  • ENSC 40.41
  • 52 Week Low
  • MFI $0.51
  • ENSC $2.12
  • 52 Week High
  • MFI $14.49
  • ENSC $14.85
  • Technical
  • Relative Strength Index (RSI)
  • MFI N/A
  • ENSC 41.25
  • Support Level
  • MFI N/A
  • ENSC $5.34
  • Resistance Level
  • MFI N/A
  • ENSC $6.19
  • Average True Range (ATR)
  • MFI 0.00
  • ENSC 0.44
  • MACD
  • MFI 0.00
  • ENSC -0.04
  • Stochastic Oscillator
  • MFI 0.00
  • ENSC 32.79

About MFI MF INTERNATIONAL LIMITED

mF International Ltd is a holding company and all of its operations are carried out by Operating Subsidiaries in Hong Kong. It is a financial trading solution provider principally engaged in the development and provision of financial trading solutions. It has experience in providing real-time mission-critical forex, bullion/commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company has provided a wide range of top-notch services, including mF4 Trading Platform, Bridge and Plugins, CRM System, ECN System, Liquidity Solutions, Cross-platform Broker Plus Solution, Social Trading Applications and others.

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

Share on Social Networks: